RxDoctor Payments DataLook up a doctor →

Abhijeet Dhoble

Interventional Cardiology · Houston, TXNPI 1407048549

Payments from drug & device makers

$2,731,020in general payments, 2019–2025

Across 726 payments — averaging $3761.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1.5M
  • Boston Scientific$929K
  • Abbott$245K
  • Medtronic$73K
  • Cathworks, Inc.$10K
  • Canon Medical Systems USA, Inc.$4K
  • plus $2K from 12 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,731,020 in reported general payments places this provider in the 95th percentile of 686 interventional cardiology providers in Texas.

See all interventional cardiology providers in Texas

Medicare billing

Part B allowed, 2024
$163,713
Medicare patients
629
Services billed
1,560

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →